Connected Health Market: The Intersection of Biomedicine and Digital Intelligence
Speak directly to the analyst to clarify any post sales queries you may have.
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices. In addition to forecasts for IoT connected healthcare devices (standalone, wearable, and implantable), the report also assesses the outlook for various biomedical products, services, and solutions poised to benefit from various IT and telecom technologies.
The field of biomedicine represents a sophisticated intersection of various natural science disciplines, including biology, chemistry, and physics, synthesized to advance our understanding of human health. It is fundamentally dedicated to the creation of innovative interventions, therapeutic modalities, and medical technologies that enhance clinical practice.
Parallel to this, the Information and Communications Technology (ICT) sector encompasses the vast infrastructure of telecommunications and computing, focusing on the seamless integration of hardware and software to manage data. This sector is often categorized within the broader TMT framework - Technology, Media, and Telecommunications, which accounts for the convergence of digital systems, broadcast media, and data transmission. Together, these industries form the backbone of modern digital commerce, content distribution, and interactive applications.
The deliberate convergence of biomedical science and ICT signifies a monumental shift for both the healthcare and technology industries, creating a high-growth area characterized by cross-disciplinary innovation. Beyond the traditional objectives of eradicating diseases and preventing chronic ailments, the marriage of these fields is designed to enhance the precision of medical treatments.
By leveraging digital tools, providers can improve the overall efficacy of care while streamlining the logistics of healthcare delivery. This synergy ensures that medical services are not only more effective but also more accessible and systematically organized, transforming the patient experience from a fragmented process into a cohesive, data-driven journey.
Addressing the economic challenges of modern medicine is perhaps the most urgent driver of this technological integration. Healthcare expenditures consistently outpace general inflation, threatening the sustainability of global health systems. Consequently, there is a critical need to improve patient outcomes while simultaneously reducing the financial burden of care.
This involves optimizing operational expenditures and mitigating the immense costs associated with research and development. In areas like pharmaceutical drug discovery and vaccine development, the application of precision medicine, which tailors treatment to individual genetic profiles, is essential for reducing the wasted resources often found in "one-size-fits-all" medical models.
The practical application of ICT in clinical settings often manifests through the Internet of Things (IoT), where enabled devices monitor patient responses to various procedures in real time. Such granular monitoring is vital when introducing new or unproven healthcare modalities.
A pertinent example involves vaccine administration and the emerging study of epigenetics, which examines how environmental factors and behaviors influence gene expression without altering the underlying DNA sequence. While a medical intervention like a vaccine is designed with the singular, positive intent of disease inoculation, ICT tools can help identify the minute subset of the population that might experience unintended physiological consequences due to their unique epigenetic markers.
One of the most dynamic subsectors of this convergence is the proliferation of wireless, IP-enabled handheld devices and wearable technologies. These tools, alongside sophisticated implantable sensors, offer a level of continuous physiological monitoring that was previously impossible in the history of medical science.
These connected devices serve as comprehensive platforms for clinical decision support and automated treatment administration. By providing clinicians with a constant stream of high-fidelity data, these technologies allow for more informed diagnoses and more rapid adjustments to treatment plans.
Ultimately, these digital tools are equally effective across both reactive and proactive medical frameworks. In reactive care, they can manage chronic conditions like diabetes through automated insulin modification; in proactive care, they can optimize vaccine schedules and formulations to prevent illness before it occurs.
The integration of ICT and biomedicine is therefore expected to yield a dual benefit: it will stabilize the economics of healthcare by lowering costs and uncovering new revenue streams through novel treatments, while simultaneously elevating the standards of global public health through personalized, data-centric care.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
Companies Mentioned
- Abbott Laboratories
- ActiveLinxx LLC
- Agfa Healthcare
- Amgen Inc.
- Analog Devices
- AstraZeneca
- Bio Rad Laboratories
- Biodirection (NanoDX)
- Biogen
- BioTelemetry (Philips Company)
- Carpenter Technology (CRS Holdings)
- Celgene Corporation
- Dentsply Sirona
- Drager
- First Sensor
- Fresenius Medical Care
- GE Healthcare
- Getinge AB
- Gilead Sciences
- Haier Biomedical
- Helmer Scientific
- Hoffman-La Roche Ltd.
- Honeywell
- Jafron Biomedical Co. Ltd.
- Johnson & Johnson Services
- KLS Martin Group
- Lifesense Group B.V.
- Lonza Group
- Medtronic
- Merck & Co.
- Nonin Medical
- Novartis AG
- Novo Nordisk
- NXP Semiconductor
- Olympus Corporation
- Panasonic
- Pfizer Inc.
- Philips Healthcare
- Samsung Healthcare
- Sanofi Aventis
- Siemens Healthineers
- Skanray Technologies
- Smiths Medical Inc.
- STMicroelectronics
- Stryker
- TE Connectivity
- Texas Instruments
- Thermo Fisher
- Wright Medical Group
- Zimmer Biomet
